# Philophos

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/philophos

- Industry: Healthcare IT
- Headquarters: Daejeon, South Korea
- Website: www.philophos.com
- Total disclosed funding: $1.5M
- Latest round: Series A (Mar 26, 2023)
- Investors on record: 6

## About

Founded in 2018 and based in Daejeon, South Korea, PHILOPHOS, INC., d.b.a. Philophos, is an optical technology development company that specializes in low-cost and compact optical coherence tomography or OCT systems. It aims to provide a retina imaging-based cost-effectively, and ultra-compact OCT through point-of-care diagnostics and teleophthalmology. The company received USD 1.5 million in Series A funding in 2022. Philophos currently provides optical technology to physicians and developers throughout the world. 

The company provides a solution for mobile optical tomography and develops core components, such as spectrometer and light source driver into a non-medical OCT system. Products include the KUOS-O100, a portable OCT scanner that folds into a small box, the KUOS-D100, a wireless OCT system, the KUSPEC-200T, an ultra-compact OCT spectrometer, and the KUD-200, an ultra-compact SLD driver. 

Philophos generates revenue by developing and manufacturing optical diagnostic devices and aims to commercialize various optical technologies. 

The company plans on designing and launching new products, making OCT-based retina imaging more cost effective and open to more patients.

## Funding rounds

- Series A, Mar 26, 2023 — Re:Ventures
- Series A, Jan 24, 2022, $1.5M — ROI Investment Partners, Angel Investment Network, J.K. Investments
- Seed, Jun 1, 2018 — Bluepoint Partners, Korea Tech Incubator for Startup
- Seed, Feb 28, 2018 — Bluepoint Partners

## Investors

- Bluepoint Partners (https://capitalatlas.ai/funds/bluepoint-partners) — Seed
- Korea Tech Incubator for Startup — Seed
- ROI Investment Partners (https://capitalatlas.ai/funds/roi-investment-partners) — Series A
- Angel Investment Network — Series A
- J.K. Investments — Series A
- Re:Ventures (https://capitalatlas.ai/funds/re-ventures) — Series A